# Evaluation of Safety, Tolerability and Pharmacokinetics of Single Dose of PF-06480605 in Japanese Healthy Participants

> **NCT04269538** · PHASE1 · COMPLETED · sponsor: **Telavant, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06480605
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04269538
- **Lead sponsor:** Telavant, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-19
- **Primary completion:** 2020-11-11
- **Final completion:** 2020-11-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04269538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04269538, "Evaluation of Safety, Tolerability and Pharmacokinetics of Single Dose of PF-06480605 in Japanese Healthy Participants". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04269538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*